AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Index of articles > Business > Trade Industries publications > Chemical Business Newsbase articles > December 2010 articles
Close

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-244713385/new-and-generic-drug.html" title="Facts and information about New and generic drug approvals: Prezista Oral Tablet, Tibotec.">New and generic drug approvals: Prezista Oral Tablet, Tibotec.</a>
Close Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
XML Add to My Yahoo! Add to My AOL Add to Google Subscribe in NewsGator
Frequently asked questions about RSS feeds

New and generic drug approvals: Prezista Oral Tablet, Tibotec.

Chemical Business Newsbase

| December 13, 2010 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

On 13 Dec 2010, the US Food and Drug Administration announced approval of NDA 021976 (efficacy supplement with clinical data to support) for Prezista Oral Tablet. The product contains darunavir …

View articles courtesy of your local library
Related articles from newspapers, magazines, journals, and more
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily